Understanding trends in osteoporosis drug prescribing: implications for reducing futile biomedical research

Jonathan R. Guillemot, John W. Abraham, Anthea Tinker

Open source

DOI
10.3389/fmed.2024.1454150
Published
2025-01-13
Container
Frontiers in Medicine
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2024.1454150,
  title = {Understanding trends in osteoporosis drug prescribing: implications for reducing futile biomedical research},
  author = {Jonathan R. Guillemot and John W. Abraham and Anthea Tinker},
  year = {2025},
  journal = {Frontiers in Medicine},
  doi = {10.3389/fmed.2024.1454150},
  url = {https://doi.org/10.3389/fmed.2024.1454150}
}

RIS

TY  - JOUR
TI  - Understanding trends in osteoporosis drug prescribing: implications for reducing futile biomedical research
AU  - Jonathan R. Guillemot
AU  - John W. Abraham
AU  - Anthea Tinker
PY  - 2025
JO  - Frontiers in Medicine
DO  - 10.3389/fmed.2024.1454150
UR  - https://doi.org/10.3389/fmed.2024.1454150
ER  - 

APA

Guillemot, J. R., Abraham, J. W., & Tinker, A. (2025). Understanding trends in osteoporosis drug prescribing: implications for reducing futile biomedical research. Frontiers in Medicine. https://doi.org/10.3389/fmed.2024.1454150

Source records